Physician profile
Robert J Mckenna
NPI 1942210117
$63,062.06
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,147 · 2020: $31K · 2021: $18K · 2022: $9,436 · 2023: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36,899.15 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $7,467.56 | 2019-2023 | Pds |
| Veran Medical Technologies, INC. | $7,201.49 | 2019-2021 | |
| Medical Device Business Services, INC. | $5,250.00 | 2021 | |
| Ethicon INC. | $3,281.73 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $518.90 | 2019-2023 | Opdivo |
| Pinnacle Biologics, INC | $514.58 | 2019-2022 | |
| Baxter Healthcare | $284.39 | 2019-2023 | Tisseel |
| Merck Sharp & Dohme LLC | $206.28 | 2019-2020 | |
| Medtronic, INC. | $205.64 | 2022-2023 | Signia |
| Covidien LP | $196.24 | 2020 | |
| Pulmonx Corporation | $188.85 | 2019-2022 | |
| Becton, Dickinson and Company | $142.84 | 2019 | |
| Medela LLC | $141.80 | 2019-2020 | |
| Karl Storz Endoscopy-America | $138.24 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $89.69 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $48.42 | 2019 | |
| Chiesi USA, INC. | $43.25 | 2020-2021 | |
| Ethicon Endo-Surgery INC. | $39.83 | 2019 | |
| Depuy Synthes Sales INC. | $37.94 | 2020 | |
| Medtronic Vascular, INC. | $36.90 | 2020 | |
| Atricure, INC. | $32.34 | 2019 | |
| Kci USA, INC. | $26.55 | 2021 | |
| Angiodynamics, INC. | $24.06 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.10 | 2021 | |
| Glaxosmithkline, LLC. | $12.19 | 2020 | |
| Cook Medical LLC | $11.10 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mckenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.